From: A study to design minimum data set of COVID-19 registry system
Main class | Sub class | Data element |
---|---|---|
Admission to hospital | Hospitalization | Need for hospitalization, first date of admission to hospital, discharge date, discharge status, hospital name, hospital type, hospital ID/code |
Care in an intensive care unit | Receive care in an intensive care unit, Length of stay (LOS) in ICU | |
Receive ventilation and intubation | Receive mechanical ventilation, the number of ventilator days, need to intubation, the number of intubation days | |
OVID-19 Medications | The main medications prescribed | Date, chloroquine phosphate, hydroxychloroquine, kaletra (lopinavir/ritonavir), ribavirin, remdesivir, avipiravir, oseltamivir (tamiflu), Atazanavir/ritonavir, plasma transfusion, other(s), please specify, additional comment |
The auxiliary medications prescribed | Date, naproxen, azithromycin, IVIG, sofosbuvir/daclatasvir (Sovodak), other(s), please specify, additional comment | |
Disease complications and outcome | Systemic complications | Sepsis/septic shock, multisystem inflammatory syndrome in children (MIS-C), multiorgan failure, cytokine release syndrome, acute kidney injury (AKI), acute liver injury, hepatitis |
Respiratory complications | Pneumonia, acute respiratory distress syndrome (ARDS), respiratory failure | |
Cardiovascular complications | Myocardial infarction, heart failure, arrhythmias, acute coronary syndrome, endothelialitis, vasculitis, viral myocarditis, other cardiovascular complications | |
Hematologic complications | Disseminated intravascular coagulation (DIC), thrombocytopenia, leukocytosis, leukocytopenia, pulmonary embolism (PE), deep vein thrombosis (DVT) | |
Neurologic complications | Cerebrovascular accident (CVA), meningitis, encephalopathy, other neurologic complications | |
Other complications | Date, the name of complications, additional comment | |
Outcome | Recovered/healthy, death, not recovered, other(s), please specify |